The Washington Post and CBS’s “60 Minutes” teamed up to publish an investigation about the influence that the pharmaceutical industry has had on America’s opioid epidemic.
The story takes a deep look at the way the drug industry and drug distributors first pumped huge numbers of opioids into communities, then worked with members of Congress to pass a law that would weaken the Drug Enforcement Administration. The law, which passed through Congress, makes it much harder for the DEA to stop these addictive drugs from reaching the black market.
The story has raised some questions about what the president can do from here to combat our nation’s opioid crisis. That’s the question we seek to answer this week: Can President Trump solve the opioid epidemic? How much power does the White House have to stop a crisis that kills so many Americans each year?
On this week’s episode of “Can He Do That?” we talk to Scott Higham about his year-long investigation with Post reporter Lenny Bernstein. And Dr. Andrew Kolodny, the co-director of the Opioid Policy Research Collaborative at Brandeis University’s Heller School, shares how to combat this epidemic and what role the White House can play in that process.
Each week, “Can He Do That?” examines the powers and limitations of the American presidency, focusing on one area where President Trump is seemingly breaking precedent. We answer the critical questions about what today’s news means for the future of the highest office in the nation.
The Washington Post and Live Nation will bring the “Can He Do That?” podcast to a live audience at the Warner Theatre on Nov. 7. In this live taping, political reporters Bob Woodward, David Fahrenthold and Karen Tumulty will join host Allison Michaels to review the past year in President Trump’s White House and the biggest moments that made people wonder “Can He Do That?” Tickets can be purchased now at Live Nation. Attendees are eligible to receive a free 30-day Basic Digital subscription to The Washington Post.